Esophageal cancer:Gastric cancer / Stomach cancer:Small intestine cancer:Duodenal cancer:Colorectal cancer:Liver cancer / Hepatic cancer:Pancreatic cancer:Bile duct cancer / Cholangiocarcinoma:Gallbladder cancer:Hypoglycemic event(s)
Conditions
Interventions
Observation Group:None
Sponsors
The First Affiliated Hospital of Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-80 years old; 2. Pathologically diagnosed with esophageal cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer, bile duct cancer, or gallbladder cancer; 3. Scheduled to undergo surgical treatment; 4. Complete clinical data available.
Exclusion criteria
Exclusion criteria: 1. Presence of severe cognitive impairment or consciousness disorders; 2. Complicated by severe dysfunction of major organs (e.g., heart, liver, brain, lung, kidney) or metabolic diseases; 3. Patients who did not undergo surgery or only received palliative procedures such as exploratory laparotomy; 4. Hypoglycemic events occurring outside the inpatient ward unit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of hypoglycemia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative complications;Length of hospital stay;Mortality rate;Hospitalization cost;Demographic and medical history data (sex, age, BMI, smoking history, alcohol history, diabetes, hypertension, renal disease history, liver disease history, hemodialysis history, medication history);Laboratory parameters (albumin, hemoglobin, neutrophil count, CRP, glycated hemoglobin, total bilirubin, alanine aminotransferase, urea nitrogen, fasting blood glucose, creatinine concentration, triglycerides, high-density lipoprotein, glomerular filtration rate);Tumor-related indicators (tumor type, tumor stage, neoadjuvant therapy prior to surgery, treatment phase, surgical approach, operation duration, fasting duration, nutritional modality, enteral nutrition rate, formula);Medication use (somatostatin, insulin, sulfonylureas, glinides, glucocorticoids, postoperative analgesics);Preoperative glucose variability (standard deviation or coefficient of variation, CV); | — |
Countries
China
Contacts
Public ContactZhu Huidi
The First Affiliated Hospital of Zhejiang University School of Medicine
Outcome results
None listed